These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36282697)

  • 21. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
    Pollard RB; Rockstroh JK; Pantaleo G; Asmuth DM; Peters B; Lazzarin A; Garcia F; Ellefsen K; Podzamczer D; van Lunzen J; Arastéh K; Schürmann D; Clotet B; Hardy WD; Mitsuyasu R; Moyle G; Plettenberg A; Fisher M; Fätkenheuer G; Fischl M; Taiwo B; Baksaas I; Jolliffe D; Persson S; Jelmert O; Hovden AO; Sommerfelt MA; Wendel-Hansen V; Sørensen B
    Lancet Infect Dis; 2014 Apr; 14(4):291-300. PubMed ID: 24525316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice.
    Ling L; Wu T; To KKW; Cheung KW; Lui KOL; Niu M; Lam KS; Wang CC; Li J; Wang H; Yuen KY; Chen Z
    AIDS; 2019 Mar; 33(4):F1-F12. PubMed ID: 30829743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized mice.
    Ling L; De C; Spagnuolo RA; Begum N; Falcinelli SD; Archin NM; Kovarova M; Silvestri G; Wahl A; Margolis DM; Garcia JV
    PLoS Pathog; 2023 Dec; 19(12):e1011824. PubMed ID: 38055722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
    Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound.
    López-Huertas MR; Gutiérrez C; Madrid-Elena N; Hernández-Novoa B; Olalla-Sierra J; Plana M; Delgado R; Rubio R; Muñoz-Fernández MÁ; Moreno S
    Sci Rep; 2020 Dec; 10(1):22286. PubMed ID: 33339855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.
    Fennessey CM; Pinkevych M; Immonen TT; Reynaldi A; Venturi V; Nadella P; Reid C; Newman L; Lipkey L; Oswald K; Bosche WJ; Trivett MT; Ohlen C; Ott DE; Estes JD; Del Prete GQ; Lifson JD; Davenport MP; Keele BF
    PLoS Pathog; 2017 May; 13(5):e1006359. PubMed ID: 28472156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
    Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
    J Virol; 2019 May; 93(10):. PubMed ID: 30842333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
    Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
    Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.
    Reeves DB; Peterson CW; Kiem HP; Schiffer JT
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28404854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood.
    Bitnun A; Samson L; Chun TW; Kakkar F; Brophy J; Murray D; Justement S; Soudeyns H; Ostrowski M; Mujib S; Harrigan PR; Kim J; Sandstrom P; Read SE
    Clin Infect Dis; 2014 Oct; 59(7):1012-9. PubMed ID: 24917662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice.
    Gruenbach M; Muller CKS; Schlaepfer E; Baroncini L; Russenberger D; Kadzioch NP; Escher B; Schlapschy M; Skerra A; Bredl S; Speck RF
    J Virol; 2022 Nov; 96(21):e0082722. PubMed ID: 36250708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.
    Morón-López S; Navarro J; Jimenez M; Rutsaert S; Urrea V; Puertas MC; Torrella A; De Clercq L; Ribas BP; Gálvez C; Salgado M; Vandekerckhove L; Blanco J; Crespo M; Martinez-Picado J
    Clin Infect Dis; 2019 Sep; 69(8):1320-1328. PubMed ID: 30590412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption.
    Wang CY; Wong WW; Tsai HC; Chen YH; Kuo BS; Lynn S; Blazkova J; Clarridge KE; Su HW; Lin CY; Tseng FC; Lai A; Yang FH; Lin CH; Tseng W; Lin HY; Finstad CL; Wong-Staal F; Hanson CV; Chun TW; Liao MJ
    N Engl J Med; 2019 Apr; 380(16):1535-1545. PubMed ID: 30995373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An advanced BLT-humanized mouse model for extended HIV-1 cure studies.
    Lavender KJ; Pace C; Sutter K; Messer RJ; Pouncey DL; Cummins NW; Natesampillai S; Zheng J; Goldsmith J; Widera M; Van Dis ES; Phillips K; Race B; Dittmer U; Kukolj G; Hasenkrug KJ
    AIDS; 2018 Jan; 32(1):1-10. PubMed ID: 29112072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse.
    Choudhary SK; Rezk NL; Ince WL; Cheema M; Zhang L; Su L; Swanstrom R; Kashuba AD; Margolis DM
    J Virol; 2009 Aug; 83(16):8254-8. PubMed ID: 19494021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant.
    Capoferri AA; Redd AD; Gocke CD; Clark LR; Quinn TC; Ambinder RF; Durand CM
    J Acquir Immune Defic Syndr; 2022 Mar; 89(3):297-302. PubMed ID: 34753870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities.
    Rausch JW; Le Grice SFJ
    Curr HIV Res; 2020; 18(2):99-113. PubMed ID: 31889490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques.
    O'Connor MA; Munson PV; Tunggal HC; Hajari N; Lewis TB; Bratt D; Moats C; Smedley J; Bagley KC; Mullins JI; Fuller DH
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):295-305. PubMed ID: 30398361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
    Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
    J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice.
    Weichseldorfer M; Affram Y; Heredia A; Rikhtegaran-Tehrani Z; Sajadi MM; Williams SP; Tagaya Y; Benedetti F; Ramadhani HO; Denaro F; Munawwar A; Bryant J; Zella D; Reitz M; Romerio F; Latinovic OS
    J Transl Med; 2021 Oct; 19(1):453. PubMed ID: 34717655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.